| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| DVA - DaVita HealthCare Partners Inc | SELL | -25 @ USD 146.61 | USD -3,665 | The ETF sold 25 shares of DVA on 2025-04-07. The shares were previously bought for an average price of USD 155.622. The DaVita HealthCare Partners Inc shares were sold for -5.8% lower than average price of previous purchases. This resulted in an overall loss of USD 225 The average price that the ETF previously sold DVA share for is USD 154.112 which is higher than the selling price of USD 146.61 on 2025-04-07. |
| CRL - Creightons Plc | SELL | -28 @ USD 134.07 | USD -3,754 | The ETF sold 28 shares of CRL on 2025-04-07. The shares were previously bought for an average price of USD 171.274. The Creightons Plc shares were sold for -21.7% lower than average price of previous purchases. This resulted in an overall loss of USD 1,042 The average price that the ETF previously sold CRL share for is USD 193.562 which is higher than the selling price of USD 134.07 on 2025-04-07. |
| HSIC - Henry Schein Inc | SELL | -67 @ USD 64.31 | USD -4,309 | The ETF sold 67 shares of HSIC on 2025-04-07. The shares were previously bought for an average price of USD 73.4276. The Henry Schein Inc shares were sold for -12.4% lower than average price of previous purchases. This resulted in an overall loss of USD 611 The average price that the ETF previously sold HSIC share for is USD 71.3674 which is higher than the selling price of USD 64.31 on 2025-04-07. |
| TECH - Bio-Techne Corp | SELL | -85 @ USD 52.31 | USD -4,446 | The ETF sold 85 shares of TECH on 2025-04-07. The shares were previously bought for an average price of USD 66.454. The Bio-Techne Corp shares were sold for -21.3% lower than average price of previous purchases. This resulted in an overall loss of USD 1,202 The average price that the ETF previously sold TECH share for is USD 72.1318 which is higher than the selling price of USD 52.31 on 2025-04-07. |
| MRNA - Moderna Inc | SELL | -179 @ USD 25.64 | USD -4,590 | The ETF sold 179 shares of MRNA on 2025-04-07. The shares were previously bought for an average price of USD 36.3054. The Moderna Inc shares were sold for -29.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,909 The average price that the ETF previously sold MRNA share for is USD 42.8149 which is higher than the selling price of USD 25.64 on 2025-04-07. |
| SOLV - Solventum Corp. | SELL | -72 @ USD 65.32 | USD -4,703 | The ETF sold 72 shares of SOLV on 2025-04-07. The shares were previously bought for an average price of USD 74.8416. The Solventum Corp. shares were sold for -12.7% lower than average price of previous purchases. This resulted in an overall loss of USD 686 The average price that the ETF previously sold SOLV share for is USD 70.3598 which is higher than the selling price of USD 65.32 on 2025-04-07. |
| VTRS - Viatris Inc | SELL | -646 @ USD 7.61 | USD -4,916 | The ETF sold 646 shares of VTRS on 2025-04-07. The shares were previously bought for an average price of USD 10.5477. The Viatris Inc shares were sold for -27.9% lower than average price of previous purchases. This resulted in an overall loss of USD 1,898 The average price that the ETF previously sold VTRS share for is USD 12.4556 which is higher than the selling price of USD 7.61 on 2025-04-07. |
| INCY - Incyte Corporation | SELL | -87 @ USD 60.29 | USD -5,245 | The ETF sold 87 shares of INCY on 2025-04-07. The shares were previously bought for an average price of USD 69.6912. The Incyte Corporation shares were sold for -13.5% lower than average price of previous purchases. This resulted in an overall loss of USD 818 The average price that the ETF previously sold INCY share for is USD 73.5023 which is higher than the selling price of USD 60.29 on 2025-04-07. |
| UHS - Universal Health Services Inc | SELL | -31 @ USD 171.67 | USD -5,322 | The ETF sold 31 shares of UHS on 2025-04-07. The shares were previously bought for an average price of USD 190.316. The Universal Health Services Inc shares were sold for -9.8% lower than average price of previous purchases. This resulted in an overall loss of USD 578 The average price that the ETF previously sold UHS share for is USD 193.391 which is higher than the selling price of USD 171.67 on 2025-04-07. |
| ALGN - Align Technology Inc | SELL | -39 @ USD 153.35 | USD -5,981 | The ETF sold 39 shares of ALGN on 2025-04-07. The shares were previously bought for an average price of USD 188.921. The Align Technology Inc shares were sold for -18.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,387 The average price that the ETF previously sold ALGN share for is USD 218.426 which is higher than the selling price of USD 153.35 on 2025-04-07. |
| RVTY - Revvity Inc. | SELL | -67 @ USD 96.16 | USD -6,443 | The ETF sold 67 shares of RVTY on 2025-04-07. The shares were previously bought for an average price of USD 113.419. The Revvity Inc. shares were sold for -15.2% lower than average price of previous purchases. This resulted in an overall loss of USD 1,156 The average price that the ETF previously sold RVTY share for is USD 115.171 which is higher than the selling price of USD 96.16 on 2025-04-07. |
| HOLX - Hologic Inc | SELL | -121 @ USD 61.27 | USD -7,414 | The ETF sold 121 shares of HOLX on 2025-04-07. The shares were previously bought for an average price of USD 67.6959. The Hologic Inc shares were sold for -9.5% lower than average price of previous purchases. This resulted in an overall loss of USD 778 The average price that the ETF previously sold HOLX share for is USD 73.0946 which is higher than the selling price of USD 61.27 on 2025-04-07. |
| BAX - Baxter International Inc | SELL | -274 @ USD 28.64 | USD -7,847 | The ETF sold 274 shares of BAX on 2025-04-07. The shares were previously bought for an average price of USD 33.5986. The Baxter International Inc shares were sold for -14.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,359 The average price that the ETF previously sold BAX share for is USD 32.626 which is higher than the selling price of USD 28.64 on 2025-04-07. |
| WST - West Pharmaceutical Services Inc | SELL | -39 @ USD 201.47 | USD -7,857 | The ETF sold 39 shares of WST on 2025-04-07. The shares were previously bought for an average price of USD 260.276. The West Pharmaceutical Services Inc shares were sold for -22.6% lower than average price of previous purchases. This resulted in an overall loss of USD 2,293 The average price that the ETF previously sold WST share for is USD 311.127 which is higher than the selling price of USD 201.47 on 2025-04-07. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -110 @ USD 73.31 | USD -8,064 | The ETF sold 110 shares of COO on 2025-04-07. The shares were previously bought for an average price of USD 89.6769. The The Cooper Companies, Inc. Common Stock shares were sold for -18.3% lower than average price of previous purchases. This resulted in an overall loss of USD 1,800 The average price that the ETF previously sold COO share for is USD 97.3092 which is higher than the selling price of USD 73.31 on 2025-04-07. |
| BIIB - Biogen Inc | SELL | -79 @ USD 119.19 | USD -9,416 | The ETF sold 79 shares of BIIB on 2025-04-07. The shares were previously bought for an average price of USD 148.189. The Biogen Inc shares were sold for -19.6% lower than average price of previous purchases. This resulted in an overall loss of USD 2,291 The average price that the ETF previously sold BIIB share for is USD 160.454 which is higher than the selling price of USD 119.19 on 2025-04-07. |
| PODD - Insulet Corporation | SELL | -38 @ USD 256.23 | USD -9,737 | The ETF sold 38 shares of PODD on 2025-04-07. The shares were previously bought for an average price of USD 269.112. The Insulet Corporation shares were sold for -4.8% lower than average price of previous purchases. This resulted in an overall loss of USD 490 The average price that the ETF previously sold PODD share for is USD 261.071 which is higher than the selling price of USD 256.23 on 2025-04-07. |
| DGX - Quest Diagnostics Incorporated | SELL | -61 @ USD 164.31 | USD -10,023 | The ETF sold 61 shares of DGX on 2025-04-07. The shares were previously bought for an average price of USD 166.319. The Quest Diagnostics Incorporated shares were sold for -1.2% lower than average price of previous purchases. This resulted in an overall loss of USD 123 The average price that the ETF previously sold DGX share for is USD 158.719 so the ETF has sold 61 shares on 2025-04-07 at a higher price than the previous selling average. |
| LH - Laboratory Corporation of America Holdings | SELL | -45 @ USD 223.5 | USD -10,058 | The ETF sold 45 shares of LH on 2025-04-07. The shares were previously bought for an average price of USD 241.619. The Laboratory Corporation of America Holdings shares were sold for -7.5% lower than average price of previous purchases. This resulted in an overall loss of USD 815 The average price that the ETF previously sold LH share for is USD 236.218 which is higher than the selling price of USD 223.5 on 2025-04-07. |
| MOH - MOH | SELL | -30 @ USD 340.38 | USD -10,211 | The ETF sold 30 shares of MOH on 2025-04-07. The shares were previously bought for an average price of USD 308.09. The MOH shares were sold for 10.5% higher than average price of previous purchases. This sale made a profit of USD 969 The average price that the ETF previously sold MOH share for is USD 305.5 so the ETF has sold 30 shares on 2025-04-07 at a higher price than the previous selling average. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -30 @ USD 340.38 | USD -10,211 | The ETF sold 30 shares of MOH on 2025-04-07. The shares were previously bought for an average price of USD 308.09. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for 10.5% higher than average price of previous purchases. This sale made a profit of USD 969 The average price that the ETF previously sold MOH share for is USD 305.5 so the ETF has sold 30 shares on 2025-04-07 at a higher price than the previous selling average. |
| WAT - Waters Corporation | SELL | -32 @ USD 325.8 | USD -10,426 | The ETF sold 32 shares of WAT on 2025-04-07. The shares were previously bought for an average price of USD 371.732. The Waters Corporation shares were sold for -12.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,470 The average price that the ETF previously sold WAT share for is USD 374.994 which is higher than the selling price of USD 325.8 on 2025-04-07. |
| WAT - MULETFWATIMETFP | SELL | -32 @ USD 325.8 | USD -10,426 | The ETF sold 32 shares of WAT on 2025-04-07. The shares were previously bought for an average price of USD 371.732. The MULETFWATIMETFP shares were sold for -12.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,470 The average price that the ETF previously sold WAT share for is USD 374.994 which is higher than the selling price of USD 325.8 on 2025-04-07. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -107 @ USD 104.84 | USD -11,218 | The ETF sold 107 shares of ZBH on 2025-04-07. The shares were previously bought for an average price of USD 107.914. The Zimmer Biomet Holdings Inc shares were sold for -2.8% lower than average price of previous purchases. This resulted in an overall loss of USD 329 The average price that the ETF previously sold ZBH share for is USD 107.844 which is higher than the selling price of USD 104.84 on 2025-04-07. |
| MTD - Mettler-Toledo International Inc | SELL | -11 @ USD 1032.15 | USD -11,354 | The ETF sold 11 shares of MTD on 2025-04-07. The shares were previously bought for an average price of USD 1254.84. The Mettler-Toledo International Inc shares were sold for -17.7% lower than average price of previous purchases. This resulted in an overall loss of USD 2,450 The average price that the ETF previously sold MTD share for is USD 1250.58 which is higher than the selling price of USD 1032.15 on 2025-04-07. |
| MTD - AMUNDI EUR GOV 710 | SELL | -11 @ USD 1032.15 | USD -11,354 | The ETF sold 11 shares of MTD on 2025-04-07. The shares were previously bought for an average price of USD 1254.84. The AMUNDI EUR GOV 710 shares were sold for -17.7% lower than average price of previous purchases. This resulted in an overall loss of USD 2,450 The average price that the ETF previously sold MTD share for is USD 1250.58 which is higher than the selling price of USD 1032.15 on 2025-04-07. |
| STE - STERIS plc | SELL | -54 @ USD 212.76 | USD -11,489 | The ETF sold 54 shares of STE on 2025-04-07. The shares were previously bought for an average price of USD 221.85. The STERIS plc shares were sold for -4.1% lower than average price of previous purchases. This resulted in an overall loss of USD 491 The average price that the ETF previously sold STE share for is USD 214.583 which is higher than the selling price of USD 212.76 on 2025-04-07. |
| DXCM - DexCom Inc | SELL | -212 @ USD 61.63 | USD -13,066 | The ETF sold 212 shares of DXCM on 2025-04-07. The shares were previously bought for an average price of USD 78.1718. The DexCom Inc shares were sold for -21.2% lower than average price of previous purchases. This resulted in an overall loss of USD 3,507 The average price that the ETF previously sold DXCM share for is USD 75.5776 which is higher than the selling price of USD 61.63 on 2025-04-07. |
| IQV - IQVIA Holdings Inc | SELL | -91 @ USD 153.01 | USD -13,924 | The ETF sold 91 shares of IQV on 2025-04-07. The shares were previously bought for an average price of USD 195.932. The IQVIA Holdings Inc shares were sold for -21.9% lower than average price of previous purchases. This resulted in an overall loss of USD 3,906 The average price that the ETF previously sold IQV share for is USD 200.586 which is higher than the selling price of USD 153.01 on 2025-04-07. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -246 @ USD 60.99 | USD -15,004 | The ETF sold 246 shares of GEHC on 2025-04-07. The shares were previously bought for an average price of USD 86.402. The GE HealthCare Technologies Inc. shares were sold for -29.4% lower than average price of previous purchases. This resulted in an overall loss of USD 6,251 The average price that the ETF previously sold GEHC share for is USD 82.2345 which is higher than the selling price of USD 60.99 on 2025-04-07. |
| A - Agilent Technologies Inc | SELL | -155 @ USD 103.59 | USD -16,056 | The ETF sold 155 shares of A on 2025-04-07. The shares were previously bought for an average price of USD 130.969. The Agilent Technologies Inc shares were sold for -20.9% lower than average price of previous purchases. This resulted in an overall loss of USD 4,244 The average price that the ETF previously sold A share for is USD 134.224 which is higher than the selling price of USD 103.59 on 2025-04-07. |
| HUM - Hummingbird Resources PLC | SELL | -65 @ USD 254.71 | USD -16,556 | The ETF sold 65 shares of HUM on 2025-04-07. The shares were previously bought for an average price of USD 271.518. The Hummingbird Resources PLC shares were sold for -6.2% lower than average price of previous purchases. This resulted in an overall loss of USD 1,093 The average price that the ETF previously sold HUM share for is USD 278.607 which is higher than the selling price of USD 254.71 on 2025-04-07. |
| HUM - Humana Inc | SELL | -65 @ USD 254.71 | USD -16,556 | The ETF sold 65 shares of HUM on 2025-04-07. The shares were previously bought for an average price of USD 271.518. The Humana Inc shares were sold for -6.2% lower than average price of previous purchases. This resulted in an overall loss of USD 1,093 The average price that the ETF previously sold HUM share for is USD 278.607 which is higher than the selling price of USD 254.71 on 2025-04-07. |
| CAH - Cardinal Health Inc | SELL | -132 @ USD 125.68 | USD -16,590 | The ETF sold 132 shares of CAH on 2025-04-07. The shares were previously bought for an average price of USD 127.147. The Cardinal Health Inc shares were sold for -1.2% lower than average price of previous purchases. This resulted in an overall loss of USD 194 The average price that the ETF previously sold CAH share for is USD 121.218 so the ETF has sold 132 shares on 2025-04-07 at a higher price than the previous selling average. |
| CNC - Concurrent Technologies Plc | SELL | -271 @ USD 61.35 | USD -16,626 | The ETF sold 271 shares of CNC on 2025-04-07. The shares were previously bought for an average price of USD 60.022. The Concurrent Technologies Plc shares were sold for 2.2% higher than average price of previous purchases. This sale made a profit of USD 360 The average price that the ETF previously sold CNC share for is USD 60.0006 so the ETF has sold 271 shares on 2025-04-07 at a higher price than the previous selling average. |
| IDXX - IDEXX Laboratories Inc | SELL | -44 @ USD 378.99 | USD -16,676 | The ETF sold 44 shares of IDXX on 2025-04-07. The shares were previously bought for an average price of USD 438.569. The IDEXX Laboratories Inc shares were sold for -13.6% lower than average price of previous purchases. This resulted in an overall loss of USD 2,621 The average price that the ETF previously sold IDXX share for is USD 426.036 which is higher than the selling price of USD 378.99 on 2025-04-07. |
| RMD - ResMed Inc | SELL | -80 @ USD 213 | USD -17,040 | The ETF sold 80 shares of RMD on 2025-04-07. The shares were previously bought for an average price of USD 234.489. The ResMed Inc shares were sold for -9.2% lower than average price of previous purchases. This resulted in an overall loss of USD 1,719 The average price that the ETF previously sold RMD share for is USD 240.69 which is higher than the selling price of USD 213 on 2025-04-07. |
| EW - Edwards Lifesciences Corp | SELL | -320 @ USD 69 | USD -22,080 | The ETF sold 320 shares of EW on 2025-04-07. The shares were previously bought for an average price of USD 71.1015. The Edwards Lifesciences Corp shares were sold for -3.0% lower than average price of previous purchases. This resulted in an overall loss of USD 672 The average price that the ETF previously sold EW share for is USD 70.1778 which is higher than the selling price of USD 69 on 2025-04-07. |
| COR - Cencora Inc. | SELL | -94 @ USD 274.56 | USD -25,809 | The ETF sold 94 shares of COR on 2025-04-07. The shares were previously bought for an average price of USD 251.456. The Cencora Inc. shares were sold for 9.2% higher than average price of previous purchases. This sale made a profit of USD 2,172 The average price that the ETF previously sold COR share for is USD 243.608 so the ETF has sold 94 shares on 2025-04-07 at a higher price than the previous selling average. |
| HCA - HCA Holdings Inc | SELL | -97 @ USD 329.63 | USD -31,974 | The ETF sold 97 shares of HCA on 2025-04-07. The shares were previously bought for an average price of USD 337.144. The HCA Holdings Inc shares were sold for -2.2% lower than average price of previous purchases. This resulted in an overall loss of USD 729 The average price that the ETF previously sold HCA share for is USD 325.502 so the ETF has sold 97 shares on 2025-04-07 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -156 @ USD 205.08 | USD -31,992 | The ETF sold 156 shares of BDX on 2025-04-07. The shares were previously bought for an average price of USD 230.837. The Becton Dickinson and Company shares were sold for -11.2% lower than average price of previous purchases. This resulted in an overall loss of USD 4,018 The average price that the ETF previously sold BDX share for is USD 226.402 which is higher than the selling price of USD 205.08 on 2025-04-07. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -57 @ USD 572.78 | USD -32,648 | The ETF sold 57 shares of REGN on 2025-04-07. The shares were previously bought for an average price of USD 716.103. The Regeneron Pharmaceuticals Inc shares were sold for -20.0% lower than average price of previous purchases. This resulted in an overall loss of USD 8,169 The average price that the ETF previously sold REGN share for is USD 761.816 which is higher than the selling price of USD 572.78 on 2025-04-07. |
| ZTS - Zoetis Inc | SELL | -243 @ USD 149.1 | USD -36,231 | The ETF sold 243 shares of ZTS on 2025-04-07. The shares were previously bought for an average price of USD 168.375. The Zoetis Inc shares were sold for -11.4% lower than average price of previous purchases. This resulted in an overall loss of USD 4,684 The average price that the ETF previously sold ZTS share for is USD 172.948 which is higher than the selling price of USD 149.1 on 2025-04-07. |
| CVS - CVS Health Corp | SELL | -684 @ USD 63.85 | USD -43,673 | The ETF sold 684 shares of CVS on 2025-04-07. The shares were previously bought for an average price of USD 62.6022. The CVS Health Corp shares were sold for 2.0% higher than average price of previous purchases. This sale made a profit of USD 853 The average price that the ETF previously sold CVS share for is USD 54.6863 so the ETF has sold 684 shares on 2025-04-07 at a higher price than the previous selling average. |
| MCK - McKesson Corporation | SELL | -68 @ USD 661.97 | USD -45,014 | The ETF sold 68 shares of MCK on 2025-04-07. The shares were previously bought for an average price of USD 613.909. The McKesson Corporation shares were sold for 7.8% higher than average price of previous purchases. This sale made a profit of USD 3,268 The average price that the ETF previously sold MCK share for is USD 596.876 so the ETF has sold 68 shares on 2025-04-07 at a higher price than the previous selling average. |
| CI - Cigna Corp | SELL | -149 @ USD 315.39 | USD -46,993 | The ETF sold 149 shares of CI on 2025-04-07. The shares were previously bought for an average price of USD 315.276. The Cigna Corp shares were sold for 0.0% higher than average price of previous purchases. This sale made a profit of USD 17 The average price that the ETF previously sold CI share for is USD 312.422 so the ETF has sold 149 shares on 2025-04-07 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -126 @ USD 423.14 | USD -53,316 | The ETF sold 126 shares of ELV on 2025-04-07. The shares were previously bought for an average price of USD 410.613. The Elevance Health Inc shares were sold for 3.1% higher than average price of previous purchases. This sale made a profit of USD 1,578 The average price that the ETF previously sold ELV share for is USD 401.348 so the ETF has sold 126 shares on 2025-04-07 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -126 @ USD 423.14 | USD -53,316 | The ETF sold 126 shares of ELV on 2025-04-07. The shares were previously bought for an average price of USD 410.613. The Elevance Health Inc shares were sold for 3.1% higher than average price of previous purchases. This sale made a profit of USD 1,578 The average price that the ETF previously sold ELV share for is USD 401.348 so the ETF has sold 126 shares on 2025-04-07 at a higher price than the previous selling average. |
| MDT - Medtronic PLC | SELL | -697 @ USD 83.15 | USD -57,956 | The ETF sold 697 shares of MDT on 2025-04-07. The shares were previously bought for an average price of USD 89.2052. The Medtronic PLC shares were sold for -6.8% lower than average price of previous purchases. This resulted in an overall loss of USD 4,220 The average price that the ETF previously sold MDT share for is USD 85.4985 which is higher than the selling price of USD 83.15 on 2025-04-07. |
| BMY - Bloomsbury Publishing Plc | SELL | -1,102 @ USD 55.19 | USD -60,819 | The ETF sold 1102 shares of BMY on 2025-04-07. The shares were previously bought for an average price of USD 58.1671. The Bloomsbury Publishing Plc shares were sold for -5.1% lower than average price of previous purchases. This resulted in an overall loss of USD 3,281 The average price that the ETF previously sold BMY share for is USD 57.0978 which is higher than the selling price of USD 55.19 on 2025-04-07. |
| DHR - Danaher Corporation | SELL | -348 @ USD 180.62 | USD -62,856 | The ETF sold 348 shares of DHR on 2025-04-07. The shares were previously bought for an average price of USD 218.674. The Danaher Corporation shares were sold for -17.4% lower than average price of previous purchases. This resulted in an overall loss of USD 13,243 The average price that the ETF previously sold DHR share for is USD 234.657 which is higher than the selling price of USD 180.62 on 2025-04-07. |
| DHR - Danaher Corporation | SELL | -348 @ USD 180.62 | USD -62,856 | The ETF sold 348 shares of DHR on 2025-04-07. The shares were previously bought for an average price of USD 218.674. The Danaher Corporation shares were sold for -17.4% lower than average price of previous purchases. This resulted in an overall loss of USD 13,243 The average price that the ETF previously sold DHR share for is USD 234.657 which is higher than the selling price of USD 180.62 on 2025-04-07. |
| SYK - Stryker Corporation | SELL | -187 @ USD 345.34 | USD -64,579 | The ETF sold 187 shares of SYK on 2025-04-07. The shares were previously bought for an average price of USD 380.491. The Stryker Corporation shares were sold for -9.2% lower than average price of previous purchases. This resulted in an overall loss of USD 6,573 The average price that the ETF previously sold SYK share for is USD 375.417 which is higher than the selling price of USD 345.34 on 2025-04-07. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -139 @ USD 474.56 | USD -65,964 | The ETF sold 139 shares of VRTX on 2025-04-07. The shares were previously bought for an average price of USD 479.413. The Vertex Pharmaceuticals Inc shares were sold for -1.0% lower than average price of previous purchases. This resulted in an overall loss of USD 675 The average price that the ETF previously sold VRTX share for is USD 464.398 so the ETF has sold 139 shares on 2025-04-07 at a higher price than the previous selling average. |
| PFE - Pfizer Inc | SELL | -3,075 @ USD 22.63 | USD -69,587 | The ETF sold 3075 shares of PFE on 2025-04-07. The shares were previously bought for an average price of USD 26.0705. The Pfizer Inc shares were sold for -13.2% lower than average price of previous purchases. This resulted in an overall loss of USD 10,580 The average price that the ETF previously sold PFE share for is USD 26.2069 which is higher than the selling price of USD 22.63 on 2025-04-07. |
| GILD - Guild Esports Plc | SELL | -676 @ USD 105.52 | USD -71,332 | The ETF sold 676 shares of GILD on 2025-04-07. The shares were previously bought for an average price of USD 102.997. The Guild Esports Plc shares were sold for 2.4% higher than average price of previous purchases. This sale made a profit of USD 1,706 The average price that the ETF previously sold GILD share for is USD 93.8783 so the ETF has sold 676 shares on 2025-04-07 at a higher price than the previous selling average. |
| BSX - Boston Scientific Corporation | SELL | -801 @ USD 91.54 | USD -73,324 | The ETF sold 801 shares of BSX on 2025-04-07. The shares were previously bought for an average price of USD 98.4145. The Boston Scientific Corporation shares were sold for -7.0% lower than average price of previous purchases. This resulted in an overall loss of USD 5,506 The average price that the ETF previously sold BSX share for is USD 89.8867 so the ETF has sold 801 shares on 2025-04-07 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -801 @ USD 91.54 | USD -73,324 | The ETF sold 801 shares of BSX on 2025-04-07. The shares were previously bought for an average price of USD 98.4145. The MULSTRXSSXIMETFP shares were sold for -7.0% lower than average price of previous purchases. This resulted in an overall loss of USD 5,506 The average price that the ETF previously sold BSX share for is USD 89.8867 so the ETF has sold 801 shares on 2025-04-07 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -292 @ USD 289.69 | USD -84,589 | The ETF sold 292 shares of AMGN on 2025-04-07. The shares were previously bought for an average price of USD 305.685. The Amgen Inc shares were sold for -5.2% lower than average price of previous purchases. This resulted in an overall loss of USD 4,671 The average price that the ETF previously sold AMGN share for is USD 290.195 which is higher than the selling price of USD 289.69 on 2025-04-07. |
| ISRG - Intuitive Surgical Inc | SELL | -194 @ USD 463.62 | USD -89,942 | The ETF sold 194 shares of ISRG on 2025-04-07. The shares were previously bought for an average price of USD 543.288. The Intuitive Surgical Inc shares were sold for -14.7% lower than average price of previous purchases. This resulted in an overall loss of USD 15,456 The average price that the ETF previously sold ISRG share for is USD 531.516 which is higher than the selling price of USD 463.62 on 2025-04-07. |
| TMO - Time Out Group plc | SELL | -208 @ USD 437.87 | USD -91,077 | The ETF sold 208 shares of TMO on 2025-04-07. The shares were previously bought for an average price of USD 530.968. The Time Out Group plc shares were sold for -17.5% lower than average price of previous purchases. This resulted in an overall loss of USD 19,364 The average price that the ETF previously sold TMO share for is USD 529.693 which is higher than the selling price of USD 437.87 on 2025-04-07. |
| MRK - Marks Electrical Group PLC | SELL | -1,375 @ USD 81.18 | USD -111,623 | The ETF sold 1375 shares of MRK on 2025-04-07. The shares were previously bought for an average price of USD 93.0405. The Marks Electrical Group PLC shares were sold for -12.7% lower than average price of previous purchases. This resulted in an overall loss of USD 16,308 The average price that the ETF previously sold MRK share for is USD 100.189 which is higher than the selling price of USD 81.18 on 2025-04-07. |
| MRK - Merck & Company Inc | SELL | -1,375 @ USD 81.18 | USD -111,623 | The ETF sold 1375 shares of MRK on 2025-04-07. The shares were previously bought for an average price of USD 93.0405. The Merck & Company Inc shares were sold for -12.7% lower than average price of previous purchases. This resulted in an overall loss of USD 16,308 The average price that the ETF previously sold MRK share for is USD 100.189 which is higher than the selling price of USD 81.18 on 2025-04-07. |
| ABT - Abbott Laboratories | SELL | -941 @ USD 124.86 | USD -117,493 | The ETF sold 941 shares of ABT on 2025-04-07. The shares were previously bought for an average price of USD 126.661. The Abbott Laboratories shares were sold for -1.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,695 The average price that the ETF previously sold ABT share for is USD 117.008 so the ETF has sold 941 shares on 2025-04-07 at a higher price than the previous selling average. |
| ABBV - AbbVie Inc | SELL | -959 @ USD 186.55 | USD -178,901 | The ETF sold 959 shares of ABBV on 2025-04-07. The shares were previously bought for an average price of USD 194.397. The AbbVie Inc shares were sold for -4.0% lower than average price of previous purchases. This resulted in an overall loss of USD 7,525 The average price that the ETF previously sold ABBV share for is USD 185.528 so the ETF has sold 959 shares on 2025-04-07 at a higher price than the previous selling average. |
| JNJ - Johnson & Johnson | SELL | -1,308 @ USD 150.62 | USD -197,011 | The ETF sold 1308 shares of JNJ on 2025-04-07. The shares were previously bought for an average price of USD 158.317. The Johnson & Johnson shares were sold for -4.9% lower than average price of previous purchases. This resulted in an overall loss of USD 10,068 The average price that the ETF previously sold JNJ share for is USD 152.778 which is higher than the selling price of USD 150.62 on 2025-04-07. |
| UNH - UnitedHealth Group Incorporated | SELL | -500 @ USD 524.7 | USD -262,350 | The ETF sold 500 shares of UNH on 2025-04-07. The shares were previously bought for an average price of USD 536.071. The UnitedHealth Group Incorporated shares were sold for -2.1% lower than average price of previous purchases. This resulted in an overall loss of USD 5,685 The average price that the ETF previously sold UNH share for is USD 565.681 which is higher than the selling price of USD 524.7 on 2025-04-07. |
| LLY - Eli Lilly and Company | SELL | -428 @ USD 723.73 | USD -309,756 | The ETF sold 428 shares of LLY on 2025-04-07. The shares were previously bought for an average price of USD 842.018. The Eli Lilly and Company shares were sold for -14.0% lower than average price of previous purchases. This resulted in an overall loss of USD 50,627 The average price that the ETF previously sold LLY share for is USD 798.617 which is higher than the selling price of USD 723.73 on 2025-04-07. |